Ardelyx, Inc. (ARDX)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Biopharmaceutical Products	333.62M
Biopharmaceutical Products Growth	168.06%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States	319.20M
United States Growth	283.30%
Asia Pacific	14.34M
Asia Pacific Growth	-65.12%
North America	78.00K
North America Growth	32.20%